Indivior To Pay $86M In Multistate Settlement For Its Role In Opioid Crisis
NEW YORK — Suboxone maker Indivior has agreed to a $86 million settlement with multiple states to settle allegations that its buprenorphine-based products that are used to treat opioid use disorder...To view the full article, register now.
Already a subscriber? Click here to view full article